YON E Health raises Pre-Seed Investment

YON E Health raises €250,000 Pre-Seed Investment

We’re incredibly excited to have been part of YON E Health’s journey in securing funding — all within record speed, closing the deal in just two months, from scratch.

This wouldn’t have been possible without Roswitha Verwer’s, the founder’s, unstoppable drive. She built strong value propositions for her vision with a sense of urgency that were both pivotal in getting the deal across the finish line.

This is exactly why we do this work. At UniPrisma Venture Studio, we align a founder’s drive for change with a VC’s conviction — this time with Roswitha Verwer and Dr. Peter M. Kovacs.

In YON E Health’s own words

YON E Health raises €250,000 Pre-Seed Investment to build what the healthcare system forgot: vaginal health that’s data-driven and finally taken seriously.

When we first spoke about vaginal health and fertility, we were met with silence. But silence doesn’t create change. Data does.

We’ve officially closed our first €250,000 led by PMK-Group, a strategic accelerator at the intersection of biotech, medtech, and clinical impact. PMK focuses on disruptive innovations that address serious unmet medical needs, improve patient outcomes, and advance the global health ecosystem.

This is a signal: the vaginal health revolution is investable, scalable, and long overdue.

Why it matters

At YON E Health, we are creating a device for vaginal pH and temperature monitoring, empowering women with accurate fertility, cycle, and health insights.

No stigma. No guesswork. No waiting until things go wrong. Because vaginal health is foundational — and too many women are still left in the dark.

Why PMK Group invested

PMK funds innovation, and they accelerate it. From Europe to Asia, Dr. Peter M. Kovacs, founder of PMK — who is committed to women’s health with a PhD in gynecological disorders — has built one of the first private research networks in Eastern Europe, scaling clinical excellence in systems that once resisted it.

They bring deep operational and scientific expertise to de-risk and accelerate development, while also partnering with founders and innovators by providing capital, clinical insight, and regulatory guidance. Peter believes in bold founders, underserved markets, and science that dares to care.

The connectors who made it happen

• UniPrisma Venture Studio — Károly Szántó and Thijmen Meijer, who helped shape the term sheet, sharpening the narrative and guiding negotiations to close.
• Matias Toye, founder of Oyster Shield and Dilicheck, for outstanding support in M&A execution and fundraising readiness.

To every woman who has ever whispered, “I don’t feel heard” — we hear you.

YON E Health is now opening select conversations to complete the round with aligned co-investors. Reach them at investment@yone.global or yone.health.